Science first. Products later.

Logo
Last updated on: |Author: 2 Kapseln Bitte

Forms & Bioavailability

Free text search

Turmeric capsules differ greatly in curcumin content and uptake [1, 3]. Depending on the formulation, studies in healthy people found values many times above native curcumin, though not directly comparable [6, 7]. The EMA advises caution with biliary disease [13].

Short answer
  • Curcuminoid content varies with the raw material; turmeric powder averages around 3%
  • Uptake differs greatly by formulation (micelles, phytosomes, nanoparticles, piperine)
  • The nominal dose says little about actual uptake
  • With biliary disease, medication, pregnancy or breastfeeding, check with a doctor first

What lies behind it

Curcumin is poorly absorbed from the gut, rapidly metabolised and quickly eliminated [1]. That is why preparations with piperine, micelles, nanoparticles, liposomes or phospholipid complexes exist [1, 2]. The raw material also varies: turmeric rhizome powder contains roughly 2–6% curcuminoids [3]; in an HPLC analysis of 28 spice products, pure turmeric powder averaged 3.14% curcumin, while curry powders contained clearly less with wide variability [4].

What the sources show

Content: In an HPLC analysis of 54 foods and supplements (curcuminoids, piperine and others), 24% of the samples contained less than 20% of the declared content; products bought online stood out in particular [5]. As a worked example: 500 mg of turmeric powder at 3.14% curcumin contains roughly 16 mg curcumin by calculation; for extracts, the content is stated on the label.

Uptake: In single-dose studies with healthy adults, formulations differed greatly. Liquid micelles achieved on average a 185-fold higher AUC than native powder at 500 mg curcuminoids [6]. In a direct comparison at 207 mg curcumin, only micelles (57-fold) and a cyclodextrin complex (30-fold) were significantly above native curcumin; other approaches, including liposomes, phytosomes and piperine, showed no significant increase [7]. Another crossover study (n=30) found no significant difference between a piperine combination and a standard extract; after dose normalisation, a micellar product and a colloidal turmeric suspension (300 mg) exceeded the standard extract (1,500 mg) [8]. For a phytosome product, one study found 7.9-fold [9], another 29-fold [10]; for a nanoparticle product (30 mg), 27-fold [11]. Piperine (20 mg) raised the bioavailability of 2 g curcumin by about 2000% in a small study of 8 healthy volunteers [12].

Safety: According to the EMA monograph, Curcuma longa is not recommended, owing to possible stimulation of bile secretion, in cases of bile duct obstruction, cholangitis, liver disease, gallstones and other biliary diseases; safety in pregnancy and lactation has not been established [13]. A review describes indications of drug interactions via CYP enzymes and P-glycoprotein, mostly from laboratory and animal data [14]. In a small study, bleeding time and INR did not change significantly after 10 days of a curcumin product in patients taking platelet inhibitors or anticoagulants [15]. In breast cancer patients, tamoxifen and endoxifen levels fell under curcumin plus piperine [16]. In mice with borderline iron status, dietary curcumin lowered iron parameters [17].

What this means in practice

The nominal dose alone says little. Useful are the stated curcuminoid content per serving, the type of processing and reputable sources [5, 8]. With illness, medication, pregnancy or breastfeeding, ask a doctor or pharmacist beforehand.

Limits of this statement

The figures come from small single-dose studies, each with its own products and methods, and are not directly comparable; higher blood levels do not automatically mean a health benefit. Iron and interaction data partly come from animal or laboratory experiments. There are no approved EU health claims for curcumin. This answer does not replace medical advice.

Common follow-up questions

No. Formulations differ greatly in absorption: in a crossover study in healthy volunteers, curcuminoid uptake was 1.3- to 45.9-fold that of an unformulated standard, depending on the formulation (Jäger et al., 2014) DOI. Content varies too: pure turmeric powder averaged 3.14% curcumin, while curry powders contained much less and varied widely (Tayyem et al., 2006) DOI. In addition, a review found 20% of 2,235 commercial turmeric samples adulterated (dietary supplements: 22%) (Gafner et al., 2025) DOI.

In a crossover trial in 12 healthy adults (single dose of 207 mg curcumin), the AUC was significantly higher than with native curcumin only for micellar curcumin (57-fold) and the curcumin-γ-cyclodextrin complex (30-fold). The increase was not significant for liposomes, phytosomes, formulations with turmeric oils or piperine, and submicron particles (Flory et al., 2021) DOI. This applies to the products tested, not to capsules in general.

It depends on the product and is stated on the label. Pure turmeric powder averaged 3.14% curcumin (Tayyem et al., 2006) DOI; for a capsule with 500 mg of powder that works out to roughly 16 mg (own calculation, assumed fill weight). In eight commercial turmeric supplements, products with a higher curcuminoid load per capsule delivered more bioaccessible curcuminoid, yet no product released more than 40% (Gurley et al., 2026) DOI.

In one study, piperine (20 mg) given with 2 g curcumin raised bioavailability by 2000% (about 20-fold) in volunteers; piperine inhibits glucuronidation (Shoba et al., 1998) DOI. In a later comparison, the increase with piperine-containing preparations was not significant (Flory et al., 2021) DOI. Piperine can also affect metabolizing enzymes and transporters and thereby alter the effects of medications (Lee et al., 2018) DOI. If you take medication, talk to your doctor first.

There is no guarantee, but checks make sense: a review found adulteration in 20% of 2,235 turmeric samples (dietary supplements: 22%) (Gafner et al., 2025) DOI. In a laboratory test of eight products, several marketed as "enhanced" showed poor disintegration and low bioaccessibility (Gurley et al., 2026) DOI. So look for analysed curcuminoid amounts per capsule, transparent manufacturer information and independent lab reports.

Further reading

  • Intake guide: Bioavailability, modern formulations and the role of bioenhancers.
  • Safety check: Safety, interactions and potential risks.
  • Effects overview: General questions and areas of use of the turmeric active ingredient.
  • Joint focus: Inflammatory processes and joint complaints in an overview of studies.

References

  • [1] Anand, P. et al. (2007). Bioavailability of Curcumin: Problems and Promises. Molecular Pharmaceutics. DOI: 10.1021/mp700113r
  • [2] Jiao, Y. et al. (2009). Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator. Blood. DOI: 10.1182/blood-2008-05-155952
  • [3] Gupta, S. C., Patchva, S. & Aggarwal, B. B. (2013). Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials. The AAPS Journal. DOI: 10.1208/s12248-012-9432-8
  • [4] Tayyem, R. F. et al. (2006). Curcumin Content of Turmeric and Curry Powders. Nutrition and Cancer. DOI: 10.1207/s15327914nc5502_2
  • [5] Brusač, E. et al. (2022). Determination of Curcuminoids, Piperine, Boswellic Acids and Andrographolides in Food and Dietary Supplements by HPLC. Food Technology and Biotechnology. DOI: 10.17113/ftb.60.04.22.7560
  • [6] Schiborr, C. et al. (2014). The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes. Molecular Nutrition & Food Research. DOI: 10.1002/mnfr.201300724
  • [7] Flory, S. et al. (2021). Increasing Post-Digestive Solubility of Curcumin Is the Most Successful Strategy to Improve its Oral Bioavailability: A Randomized Cross-Over Trial in Healthy Adults and In Vitro Bioaccessibility Experiments. Molecular Nutrition & Food Research. DOI: 10.1002/mnfr.202100613
  • [8] Fança-Berthon, P. et al. (2021). Pharmacokinetics of a Single Dose of Turmeric Curcuminoids Depends on Formulation: Results of a Human Crossover Study. The Journal of Nutrition. DOI: 10.1093/jn/nxab087
  • [9] Jäger, R. et al. (2014). Comparative absorption of curcumin formulations. Nutrition Journal. DOI: 10.1186/1475-2891-13-11
  • [10] Cuomo, J. et al. (2011). Comparative Absorption of a Standardized Curcuminoid Mixture and Its Lecithin Formulation. Journal of Natural Products. DOI: 10.1021/np1007262
  • [11] Sasaki, H. et al. (2011). Innovative Preparation of Curcumin for Improved Oral Bioavailability. Biological and Pharmaceutical Bulletin. DOI: 10.1248/bpb.34.660
  • [12] Shoba, G. et al. (1998). Influence of Piperine on the Pharmacokinetics of Curcumin in Animals and Human Volunteers. Planta Medica. DOI: 10.1055/s-2006-957450
  • [13] European Medicines Agency, HMPC (2018). European Union herbal monograph on Curcuma longa L., rhizome – Revision 1 (EMA/HMPC/329755/2017). EMA. https://www.ema.europa.eu/en/medicines/herbal/curcumae-longae-rhizoma
  • [14] Bahramsoltani, R., Rahimi, R. & Farzaei, M. H. (2017). Pharmacokinetic interactions of curcuminoids with conventional drugs: A review. Journal of Ethnopharmacology. DOI: 10.1016/j.jep.2017.07.022
  • [15] Hu, S. et al. (2018). Interaction study between antiplatelet agents, anticoagulants, thyroid replacement therapy and a bioavailable formulation of curcumin (Meriva®). European Review for Medical and Pharmacological Sciences. DOI: 10.26355/eurrev_201808_15647
  • [16] Hussaarts, K. G. A. M. et al. (2019). Impact of Curcumin (with or without Piperine) on the Pharmacokinetics of Tamoxifen. Cancers. DOI: 10.3390/cancers11030403
  • [17] Hegde, M. et al. (2023). Curcumin Formulations for Better Bioavailability: What We Learned from Clinical Trials Thus Far? ACS Omega. DOI: 10.1021/acsomega.2c07326

In the blood, curcumin appears after about 0.6–3.3 hours depending on the product [1, 2, 3]. When effects show up is not generally established: knee osteoarthritis studies ran 4–6 weeks [4, 5].

In short
  • Blood levels: peak after about 0.6 to 3.3 hours depending on the product [1, 2, 3]
  • Studies on complaints mostly lasted 4–6 weeks [4, 5]
  • An "onset" after a set number of weeks is not generally established
  • Once-daily dosing gave measurable levels in one study [6]

What's behind it

"Working" can mean two things: how fast curcumin reaches the blood after swallowing, and how long it took in studies before changes in complaints or measured values were seen. The two are studied to very different degrees.

What the sources show

Uptake into the blood. Curcumin is poorly absorbed and rapidly metabolized [7]. How fast it appears in the blood depends on the product. With a lipid-based formulation (750 mg), the peak came after about 0.6 hours [1]. With a nano-liposomal product (400 mg curcumin equivalent) it was 0.86 hours, with free curcumin (2,000 mg) 3.3 hours; each group in that study had only 9 healthy men [2]. After single doses of 10 or 12 g of a curcumin preparation, the peak was at about 3.3 hours and the half-life about 6.8 hours [3]. In a crossover study in healthy volunteers, once-daily dosing was enough to detect curcuminoids in plasma and rectal tissue at steady state [6].

Time frame in studies. A study of 367 people with knee osteoarthritis compared 1,500 mg of Curcuma domestica extract per day with ibuprofen over 4 weeks. Complaint scores (WOMAC) were already improved from baseline at the 2-week measurement, and at 4 weeks the extract was non-inferior to ibuprofen [4]. A small placebo-controlled study (40 people, 1,500 mg curcuminoids per day) measured greater improvements than placebo after 6 weeks [5]. When exactly changes begin, and whether there is a maximum after a given time, these studies did not examine.

Other studies ran longer: in people with type 2 diabetes (500 mg curcuminoids plus 5 mg piperine per day), glucose and liver enzymes were measured after 3 months; inflammation markers (hs-CRP) did not change [8].

What this means in practice

A turmeric product does not act like a painkiller within hours. Blood levels rise within a few hours, but the studies that looked at complaints or lab values ran for weeks to months. A fixed point in time from which you notice something is not established. For persistent complaints, see a doctor.

Limits of the statement

The times come from small studies with particular products, doses and groups; studies in healthy people cannot be transferred to people with illness. A blood level is not the same as an effect. Individual responses differ. These statements are not promises of a cure and do not replace medical treatment.

Common follow-up questions

No, there is no evidence of an immediate effect. Studies with curcuminoids measure effects after weeks: one trial in knee osteoarthritis patients gave 1,500 mg/day for 6 weeks (Panahi et al., 2014) DOI, another ran for 4 weeks with assessments at weeks 2 and 4 (Kuptniratsaikul et al., 2014) DOI. No general time span until first effects can be derived from this.

This depends strongly on the formulation. In 12 healthy fasted volunteers (376 mg curcuminoids each), the mean time to peak concentration of total curcuminoids was about 1.7 to 1.8 hours for three specialised formulations, but 9.5 hours for the unformulated mixture (Jäger et al., 2014) DOI. After single doses of 10 to 12 g, it was about 3.3 hours for curcumin conjugates (Vareed et al., 2008) DOI.

We have no efficacy data on very short intake periods; a minimum duration has not been established. The studies lasted weeks: 4 weeks with assessments at weeks 2 and 4 (Kuptniratsaikul et al., 2014) DOI, or 6 weeks (Panahi et al., 2014) DOI. The EMA advises seeking medical advice if symptoms persist for more than 2 weeks (EMA, 2018) EMA/HMPC/329755/2017.

Read more

Want to dive deeper into the subject? Continue here:

  • Intake guide: Worth knowing about bioavailability, modern formulations and the role of bioenhancers.
  • Safety check: A detailed look at safety, interactions and potential risks.
  • Effects overview: Answers to general questions about effects and application areas of the turmeric active ingredient.

References

  • [1] Pawar, Y. B. et al. (2012). Bioavailability of a lipidic formulation of curcumin in healthy human volunteers. Pharmaceutics. DOI: 10.3390/pharmaceutics4040517
  • [2] Kim, D.-S. et al. (2026). Enhanced bioavailability of a novel double-layered nano-liposomal curcumin (BNT-C060): a randomized, double-blind, clinical trial. Scientific Reports. DOI: 10.1038/s41598-026-53709-8
  • [3] Vareed, S. K. et al. (2008). Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects. Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1055-9965.EPI-07-2693
  • [4] Kuptniratsaikul, V. et al. (2014). Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis: a multicenter study. Clinical Interventions in Aging. DOI: 10.2147/CIA.S58535
  • [5] Panahi, Y. et al. (2014). Curcuminoid treatment for knee osteoarthritis: a randomized double-blind placebo-controlled trial. Phytotherapy Research. DOI: 10.1002/ptr.5174
  • [6] Asher, G. N. et al. (2016). Randomized pharmacokinetic crossover study comparing 2 curcumin preparations in plasma and rectal tissue of healthy human volunteers. The Journal of Clinical Pharmacology. DOI: 10.1002/jcph.806
  • [7] Anand, P. et al. (2007). Bioavailability of curcumin: problems and promises. Molecular Pharmaceutics. DOI: 10.1021/mp700113r
  • [8] Panahi, Y. et al. (2018). Effects of curcuminoids plus piperine on glycemic, hepatic and inflammatory biomarkers in patients with type 2 diabetes mellitus: a randomized double-blind placebo-controlled trial. Drug Research. DOI: 10.1055/s-0044-101752

Capsules usually contain standardized extracts; spice powder has only about 2–6% curcuminoids [1]. Formulations raised absorption in small studies [2, 3, 4], clinical results are mixed [5, 6]. In 2017 EFSA found no established link between curcumin and joint function [7].

Short answer
  • Powder: about 2–6% curcuminoids [1]; extracts in capsules up to 95% [8]
  • Absorption in studies 7- to 185-fold higher depending on formulation [2, 9]
  • Study results are mixed and apply only to the dose, group and product [10]
  • EFSA 2017: cause and effect for joint function not established [7]
  • Not a substitute for medical treatment

What's behind it

Turmeric powder contains only about 2–6% curcuminoids [1]; most of it is carbohydrate [11]. Capsules usually contain a standardized extract with a higher curcuminoid share, for example at least 95% in one study [8], sometimes with formulations for better absorption. This matters because curcumin is poorly absorbed and rapidly metabolized [12].

What the sources show

Absorption. In studies in healthy volunteers, formulations increased measured absorption:

  • Liquid micelles: 185-fold compared with native curcumin (23 people, 500 mg single dose) [2].
  • Lecithin phytosome: about 29-fold [3]; 7.9-fold in another study [9].
  • Nanoparticles (Theracurmin): 27-fold AUC at 30 mg [4].
  • Piperine (20 mg with 2 g curcumin): +2000% in one small study [13]. Higher absorption is not evidence of a health benefit.

Clinical studies. A review of 389 publications on orally taken curcumin found that about half concerned metabolic (29%) or musculoskeletal conditions (17%), and 75% of the publications reported favorable results for complaints or biomarkers; the authors regard the evidence in many areas as preliminary and call for larger trials [10]. Some examples:

  • Knee osteoarthritis: in a study of 367 people, 1,500 mg of Curcuma domestica extract per day was non-inferior to ibuprofen after 4 weeks (WOMAC scores) [5]. In a small placebo-controlled study (40 people, 1,500 mg curcuminoids), pain and function scores fell more than with placebo after 6 weeks [14].
  • Blood sugar: in a 9-month study of 240 people with prediabetes, the curcumin group had higher HOMA-β and lower HOMA-IR values than placebo [15]. In type 2 diabetes (500 mg + 5 mg piperine, 3 months), glucose, HbA1c and liver enzymes fell, but not hs-CRP [6].
  • Inflammation markers: a meta-analysis of six trials found lower CRP levels with curcuminoids than with placebo [16].
  • Blood lipids: a meta-analysis of 7 trials (649 people) found lower LDL cholesterol and triglyceride levels; HDL did not change clearly [17].

Regulatory assessment. In 2017, EFSA assessed an application on curcumin and normal joint function: no conclusions could be drawn from the submitted studies, and a cause-and-effect relationship was not established [7].

What this means in practice

Capsules with standardized extracts state the content and allow more exact dosing than powder. What effect this has for you cannot be derived from the studies. Do not change an ongoing treatment without talking to your doctor. More on absorption and safety under Bioavailability and Safety.

Limits of the statement

This answer is not a treatment recommendation. The studies differ in product, dose (here 500–1,500 mg per day), duration and participants and cannot be transferred to everyone. Quality and content of products vary.

Common follow-up questions

That depends on the product; only the label is reliable. Studies used, for example, 500 mg capsules of a bioavailable turmeric extract (BCM-95) twice daily (Singhal et al., 2021) DOI. In contrast, the curcumin content of turmeric spices varies: pure turmeric powder contained on average 3.14 % curcumin (Tayyem et al., 2006) DOI.

Not across the board, but certain formulations are absorbed better. In a crossover study in healthy volunteers, curcuminoid absorption was 1.3- to 45.9-fold higher, depending on the formulation, than with an unformulated standard mixture (Jäger et al., 2014) DOI. This applies to those formulations, not to every capsule; turmeric powder itself was not tested there. The curcumin content of powders also varies (Tayyem et al., 2006) DOI.

Technically this is possible, but it is no advantage over a purchased product. The curcumin content of turmeric powders varies (on average 3.14 %), and curry powders contain little and very variable amounts (Tayyem et al., 2006) DOI. In addition, unformulated curcumin is poorly absorbed, which is why various formulations were developed (Kotha et al., 2019) DOI.

They were studied, for example, for knee osteoarthritis symptoms: an extract (1,500 mg per day) was non-inferior to ibuprofen for WOMAC pain and function after 4 weeks (Kuptniratsaikul et al., 2014) DOI. A bioavailable extract also lowered CRP and TNF-α more than paracetamol over 6 weeks (Singhal et al., 2021) DOI. A meta-analysis in prediabetes and type 2 diabetes found lower CRP, TNF-α and IL-6 with low certainty of evidence (Bahari et al., 2025) DOI, and another found lower fasting blood glucose with high heterogeneity (de Melo et al., 2018) DOI.

No. Never stop or switch medication on your own; that decision belongs to your treating practice. In studies, turmeric extracts were compared with ibuprofen or paracetamol over a few weeks in knee osteoarthritis (Kuptniratsaikul et al., 2014) DOI (Singhal et al., 2021) DOI, but a meta-analysis rates the study quality as low and heterogeneous (Feng et al., 2022) DOI. For blood sugar, curcumin is studied as an adjunct; the meta-analysis shows high heterogeneity and evidence of publication bias (de Melo et al., 2018) DOI.

Further reading

  • Joint focus: Inflammatory processes and joint complaints in research.
  • Intake guide: Bioavailability, modern formulations and the role of bioenhancers.
  • Safety check: Safety, interactions and possible risks.
  • Effects overview: General questions and areas of use of the turmeric active ingredient.

References

  • [1] Gupta, S. C., Patchva, S. & Aggarwal, B. B. (2013). Therapeutic roles of curcumin: lessons learned from clinical trials. The AAPS Journal. DOI: 10.1208/s12248-012-9432-8
  • [2] Schiborr, C. et al. (2014). The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes. Molecular Nutrition & Food Research. DOI: 10.1002/mnfr.201300724
  • [3] Cuomo, J. et al. (2011). Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation. Journal of Natural Products. DOI: 10.1021/np1007262
  • [4] Sasaki, H. et al. (2011). Innovative preparation of curcumin for improved oral bioavailability. Biological and Pharmaceutical Bulletin. DOI: 10.1248/bpb.34.660
  • [5] Kuptniratsaikul, V. et al. (2014). Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis: a multicenter study. Clinical Interventions in Aging. DOI: 10.2147/CIA.S58535
  • [6] Panahi, Y. et al. (2018). Effects of curcuminoids plus piperine on glycemic, hepatic and inflammatory biomarkers in patients with type 2 diabetes mellitus: a randomized double-blind placebo-controlled trial. Drug Research. DOI: 10.1055/s-0044-101752
  • [7] EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (2017). Curcumin and normal functioning of joints: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journal. DOI: 10.2903/j.efsa.2017.4774
  • [8] Lao, C. D. et al. (2006). Dose escalation of a curcuminoid formulation. BMC Complementary and Alternative Medicine. DOI: 10.1186/1472-6882-6-10
  • [9] Jäger, R. et al. (2014). Comparative absorption of curcumin formulations. Nutrition Journal. DOI: 10.1186/1475-2891-13-11
  • [10] Panknin, T. M. et al. (2023). Curcumin supplementation and human disease: a scoping review of clinical trials. International Journal of Molecular Sciences. DOI: 10.3390/ijms24054476
  • [11] Kotha, R. R. & Luthria, D. L. (2019). Curcumin: biological, pharmaceutical, nutraceutical, and analytical aspects. Molecules. DOI: 10.3390/molecules24162930
  • [12] Anand, P. et al. (2007). Bioavailability of curcumin: problems and promises. Molecular Pharmaceutics. DOI: 10.1021/mp700113r
  • [13] Shoba, G. et al. (1998). Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Medica. DOI: 10.1055/s-2006-957450
  • [14] Panahi, Y. et al. (2014). Curcuminoid treatment for knee osteoarthritis: a randomized double-blind placebo-controlled trial. Phytotherapy Research. DOI: 10.1002/ptr.5174
  • [15] Chuengsamarn, S. et al. (2012). Curcumin extract for prevention of type 2 diabetes. Diabetes Care. DOI: 10.2337/dc12-0116
  • [16] Sahebkar, A. (2014). Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis. Phytotherapy Research. DOI: 10.1002/ptr.5045
  • [17] Qin, S. et al. (2017). Efficacy and safety of turmeric and curcumin in lowering blood lipid levels in patients with cardiovascular risk factors: a meta-analysis of randomized controlled trials. Nutrition Journal. DOI: 10.1186/s12937-017-0293-y

There is no blanket recommendation. Studies in healthy people show that formulations such as micelles or cyclodextrin complexes reach higher blood levels than native curcumin [1, 2]. A market sample found marked shortcomings in labelling and release [3, 4].

Short answer
  • Micelles: in studies 57- to 185-fold AUC compared with native curcumin, depending on the product [1, 2]
  • Cyclodextrin complex: about 30- to 39-fold AUC [1, 5]
  • Phytosome: inconsistent (no significant rise up to 29-fold) [1, 6]
  • Piperine combination: no difference from the standard extract in one study; interactions with medicines possible [7, 8]
  • Quality: in one sample only 4 of 14 products supported the natural label [3]; none released more than 40% in laboratory tests [4]

What lies behind it

The quality of a capsule depends on three points: content, uptake, and purity or authenticity. Curcumin is poorly water-soluble, so the dose on the pack says little about the amount absorbed [1]. In addition, products do not always deliver what they promise [3].

What the sources show

Uptake: In a randomised crossover study with 12 healthy adults and a single dose of 207 mg curcumin, only micelles (57-fold) and a gamma-cyclodextrin complex (30-fold) raised the AUC significantly; liposomes, phytosomes and piperine additives did not [1]. Other studies found 185-fold for liquid micelles [2], 39-fold for gamma-cyclodextrin [5] and 29-fold for the phytosome Meriva [6]. A review of eleven formulations lists NovaSol, CurcuWin and LongVida with over 100-fold bioavailability compared with unformulated curcumin [9]. The values depend on product and study design.

Piperine: With 20 mg piperine, the bioavailability of 2 g curcumin rose by 2000% in a small study [10]; in a study of 30 healthy people, a piperine-curcuminoid combination did not differ significantly from the standard extract [7]. In the laboratory, piperine inhibits CYP3A4 and P-glycoprotein and can thus affect medicines [8].

Release: Eight commercial turmeric supplements released active ingredient poorly overall in laboratory tests, none more than 40%. Some products marketed as "enhanced" disintegrated poorly and had low bioaccessibility. Release was lowest under fasted conditions and rose slightly under fed-state conditions [4].

Authenticity: Of 14 supplements with turmeric ingredients, only four supported the "natural" claim; a high share of curcumin among the curcuminoids pointed to synthetic curcumin [3]. One overview found products registered as medicines less often adulterated than food supplements [11].

What this means in practice

The data suggest these selection criteria: a traceable manufacturer statement on curcuminoid content and formulation, ideally with an analysis certificate, and human studies on the specific product. If you take medication, have piperine-containing products checked by a doctor. For intake, the manufacturer's instructions apply; release rose slightly under fed-state conditions [4].

Limits of this statement

The data come mainly from single-dose studies in small groups of healthy volunteers and from laboratory tests of a few products. They apply only to the products tested and say nothing about long-term safety of the formulations. Higher blood levels are no proof of a health benefit. We do not recommend a specific product. This answer does not replace medical advice.

Frequently asked questions

In a cross-over trial in 12 healthy adults (single dose of 207 mg curcumin), only micellar curcumin (57-fold) and the γ-cyclodextrin complex (30-fold) significantly raised the AUC over native curcumin. For other formulations (including liposomes, turmeric oils, added piperine and phytosomes) the increase was not significant (Flory et al., 2021) DOI. Whether this applies to standard extracts was not tested there.

In the same cross-over trial in 12 healthy adults, micelles raised the AUC 57-fold over native curcumin, whereas liposomes did not significantly. In the lab, micellar curcumin was 100% digestively stable and 80% soluble, other formulations below 72% and below 8%, respectively (Flory et al., 2021) DOI.

The data are mixed. In the lab, piperine inhibits CYP3A relatively selectively (Volak et al., 2008) DOI. In eight healthy volunteers, a curcuminoid-piperine extract (24 mg piperine) did not meaningfully change levels of midazolam, flurbiprofen or paracetamol (Volak et al., 2013) DOI. By contrast, 20 mg piperine daily for 10 days raised diclofenac exposure in 12 healthy people (Bedada et al., 2016) DOI. If you take medication regularly, clarify piperine capsules with your doctor first.

There is no study on this; follow the instructions on the pack. What is established is that the formulation affects absorption: a lecithin formulation (Meriva) was absorbed about 29-fold more than the unformulated curcuminoid mixture in a randomized cross-over study (Cuomo et al., 2011) DOI.

There is no study comparing times of intake. Pharmacokinetic studies in healthy people examine absorption after a single dose; a review of 11 formulations with improved bioavailability attributes the improvement mainly to better solubility and stability (Jamwal, 2018) DOI. Time of day is not described there as a factor.

Further reading

  • Intake guide: Bioavailability, modern formulations and the role of bioenhancers.
  • Safety check: Safety, interactions and possible risks.
  • Effects overview: General questions about the areas of use studied.

References

  • [1] Flory, S. et al. (2021). Increasing post-digestive solubility of curcumin is the most successful strategy to improve its oral bioavailability: a randomized cross-over trial in healthy adults and in vitro bioaccessibility experiments. Molecular Nutrition & Food Research. DOI: 10.1002/mnfr.202100613
  • [2] Schiborr, C. et al. (2014). The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes. Molecular Nutrition & Food Research. DOI: 10.1002/mnfr.201300724
  • [3] You, H. et al. (2021). Analytical strategies to determine the labelling accuracy and economically-motivated adulteration of “natural” dietary supplements in the marketplace: turmeric case study. Food Chemistry. DOI: 10.1016/j.foodchem.2021.131007
  • [4] Gurley, B. J. et al. (2026). Formulation-dependent dissolution and bioaccessibility of curcuminoids and (S)-ar-turmerone from eight commercial turmeric extract- and curcumin-containing dietary supplements. Pharmaceutical Biology. DOI: 10.1080/13880209.2026.2631826
  • [5] Purpura, M. et al. (2018). Analysis of different innovative formulations of curcumin for improved relative oral bioavailability in human subjects. European Journal of Nutrition. DOI: 10.1007/s00394-016-1376-9
  • [6] Cuomo, J. et al. (2011). Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation. Journal of Natural Products. DOI: 10.1021/np1007262
  • [7] Fança-Berthon, P. et al. (2021). Pharmacokinetics of a single dose of turmeric curcuminoids depends on formulation: results of a human crossover study. The Journal of Nutrition. DOI: 10.1093/jn/nxab087
  • [8] Bhardwaj, R. K. et al. (2002). Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4. Journal of Pharmacology and Experimental Therapeutics. DOI: 10.1124/jpet.102.034728
  • [9] Jamwal, R. (2018). Bioavailable curcumin formulations: a review of pharmacokinetic studies in healthy volunteers. Journal of Integrative Medicine. DOI: 10.1016/j.joim.2018.07.001
  • [10] Shoba, G. et al. (1998). Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Medica. DOI: 10.1055/s-2006-957450
  • [11] Orhan, N. et al. (2024). Estimating the extent of adulteration of the popular herbs black cohosh, echinacea, elder berry, ginkgo, and turmeric – its challenges and limitations. Natural Product Reports. DOI: 10.1039/d4np00014e

Turmeric powder is used as a spice in dishes or in drinks such as golden milk. Curcumin is barely water-soluble [1] and poorly absorbed from powder [2, 3]; black pepper raised absorption in one small study but can affect medicines [2, 4].

Quick answer
  • Curcumin is nearly insoluble in water; absorption from powder is low [1, 2]
  • Black pepper (piperine): about 20-fold bioavailability in one study of 8 healthy people, no difference in another [2, 5]
  • 1 tsp (2–2.5 g) contains about 63–79 mg curcumin by calculation (at 3.14%) [6]
  • The EFSA ADI for curcumin is 3 mg/kg body weight per day [7]

What lies behind it

Turmeric powder is used as a spice, for example in curries, rice dishes, soups, golden milk or smoothies. The main pigment curcumin is poorly water-soluble [1], and its uptake into the blood is a known problem that reviews discuss at length [8].

What the sources show

Absorption from powder: After 2 g of curcumin, serum levels in healthy volunteers were undetectable or very low [2]. In a dose-escalation study in patients, mean peak levels after 4–8 g of curcumin were 0.51–1.77 µM [3].

Black pepper: Together with 20 mg piperine, the bioavailability of 2 g curcumin rose by 2000% in a small study with volunteers [2]. After meals of turmeric powder with black pepper, a preliminary study found more curcumin excreted in urine [9]. In a study of 30 healthy people, however, a piperine-curcuminoid combination did not differ significantly from a standard extract [5]. The findings are therefore inconsistent. In laboratory tests, piperine inhibits the drug-metabolising enzyme CYP3A4 and the transporter P-glycoprotein, so interactions with medicines are possible [4].

Fat: We found no study testing fat directly with turmeric powder. With a highly bioavailable turmeric formulation, absorption was higher in foods containing fat, such as an oat drink [10].

Content and amount: Pure turmeric powder contained 3.14% curcumin on average [6]. One teaspoon (2–2.5 g) therefore corresponds to roughly 63–79 mg, and 3–5 g of powder to about 94–157 mg curcumin (our calculation). EFSA derived an ADI of 3 mg/kg body weight per day for curcumin (E 100), which is 210 mg for 70 kg by calculation; intake from the normal diet is below 7% of it [7]. In patient studies, curcumin doses of 500 to 12,000 mg daily were used for three months, with no treatment-related toxicity up to 8,000 mg [3]; dose-escalation studies point to safety up to 12 g daily over three months [11].

What this means in practice

As a spice in food or drinks, turmeric powder is easy to use. A meal with fat, such as oil, milk or nuts, suits curries and golden milk and, on the available data, is at least favourable for formulations. Black pepper is a common ingredient; if you take medication regularly, check larger amounts of piperine with a doctor first. Usual kitchen amounts are, by calculation, well below the ADI.

Limits of this statement

The absorption studies are small, partly in patients or with special preparations, and cannot be transferred directly to kitchen powder. The calculations rely on an average content; individual products differ. For joint function, EFSA in 2017 could not establish a cause-effect relationship from the submitted studies [12]. This answer describes general use and gives no dosing or therapy recommendation.

Frequently asked questions

Better with fat or in a meal. Curcumin is poorly water-soluble and poorly absorbed when unformulated (Jäger et al., 2014) DOI; in a small study, serum levels in humans were undetectable or very low after 2 g of curcumin alone (Shoba et al., 1998) DOI. A review reports that lipids and especially dairy-rich matrices improve the bioavailability of curcuminoids (Rak et al., 2026) DOI.

Golden milk is a drink of warm milk and turmeric, often with fat such as coconut oil or ghee. On absorption: a review reports that lipids and dairy-based systems markedly increase the bioavailability of lipophilic curcuminoids (Rak et al., 2026) DOI. How much of this arrives in the body from golden milk specifically was not measured by this.

There is no study showing this. Curcumin is poorly soluble in water and crystallizes out of acidic aqueous solutions; in oil-in-water emulsions it was better dispersible and more stable (Kharat et al., 2017) DOI. Unformulated curcumin is poorly absorbed (Jäger et al., 2014) DOI. So do not rely on hot water alone.

In a small study with eight healthy volunteers, 20 mg of piperine given with 2 g of curcumin raised bioavailability by 2000% (Shoba et al., 1998) DOI. Black pepper is not required for seasoning; the study makes no statement on this. Piperine inhibited CYP3A in the laboratory (Volak et al., 2008) DOI; in a small human study with a curcuminoid-piperine extract, midazolam, flurbiprofen and paracetamol levels nevertheless remained unchanged (Volak et al., 2013) DOI. If you take medication, talk to your doctor first.

EFSA sets an ADI of 0–3 mg per kg body weight per day for curcumin as a food additive (E 100) (EFSA, 2010) DOI. This is a value for the additive, not for spice turmeric. By calculation: at 3.14% curcumin in turmeric powder (Tayyem et al., 2006) DOI, 3–5 g contain about 94–157 mg, which is below the ADI of 210 mg for a 70 kg adult (own calculation).

Read more

  • Intake guide: Useful information on bioavailability, modern formulations and the role of bioenhancers.
  • Safety check: A detailed look at safety, interactions and potential risks.
  • Effects overview: Answers to general questions about effects and areas of use of the turmeric active ingredient.
  • Joint focus: The role of inflammatory processes in osteoarthritis and joint complaints.

References

  • [1] Priyadarsini, K. I. (2014). The chemistry of curcumin: from extraction to therapeutic agent. Molecules. DOI: 10.3390/molecules191220091
  • [2] Shoba, G. et al. (1998). Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Medica. DOI: 10.1055/s-2006-957450
  • [3] Cheng, A. L. et al. (2001). Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Research. PMID: 11712783
  • [4] Bhardwaj, R. K. et al. (2002). Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4. Journal of Pharmacology and Experimental Therapeutics. DOI: 10.1124/jpet.102.034728
  • [5] Fança-Berthon, P. et al. (2021). Pharmacokinetics of a single dose of turmeric curcuminoids depends on formulation: results of a human crossover study. The Journal of Nutrition. DOI: 10.1093/jn/nxab087
  • [6] Tayyem, R. F. et al. (2006). Curcumin content of turmeric and curry powders. Nutrition and Cancer. DOI: 10.1207/s15327914nc5502_2
  • [7] EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS) (2010). Scientific opinion on the re-evaluation of curcumin (E 100) as a food additive. EFSA Journal. DOI: 10.2903/j.efsa.2010.1679
  • [8] Prasad, S. et al. (2014). Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice. Cancer Research and Treatment. DOI: 10.4143/crt.2014.46.1.2
  • [9] Khajehpour, S. et al. (2023). Development of a rapid, sensitive, and selective LC-MS/MS method for quantifying curcumin levels in healthy human urine: effect of pepper on curcumin bioavailability. Food Science & Nutrition. DOI: 10.1002/fsn3.3691
  • [10] Schönenberger, K. A. et al. (2025). The influence of food matrices on the bioavailability of curcuminoids from a dried colloidal turmeric suspension: a randomized, crossover, clinical trial. Food & Function. DOI: 10.1039/d4fo03414g
  • [11] Gupta, S. C. et al. (2013). Therapeutic roles of curcumin: lessons learned from clinical trials. The AAPS Journal. DOI: 10.1208/s12248-012-9432-8
  • [12] EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (2017). Curcumin and normal functioning of joints: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journal. DOI: 10.2903/j.efsa.2017.4774

Spice powder and unformulated curcumin are poorly absorbed [1]. Formulations with micelles, phospholipids, nanoparticles or piperine raised absorption 7- to 185-fold in small studies [2, 3, 4, 5, 6]; a comparison of effects is lacking.

In short
  • Liquid micelles: 185-fold area under the curve (AUC) vs. native curcumin [2]
  • Lecithin phytosome: about 29-fold [3]; 7.9-fold in another study [6]
  • Nanoparticles (Theracurmin): 27-fold [4]
  • Piperine: about 20-fold in one small study [5]
  • More absorption does not mean more effect

What's behind it

Curcumin dissolves poorly, is rapidly metabolized in the gut and liver, and is eliminated quickly [1]. Formulations were therefore developed to bring more curcumin into the blood: piperine as an inhibitor of glucuronidation, phospholipid complexes, nanoparticles, micelles, or additions from the turmeric rhizome [1, 5]. "Effective" here means "better absorbed", not a health effect.

What the sources show

All numbers come from pharmacokinetic studies in healthy volunteers with different designs. They are not directly comparable.

  • Piperine: After 2 g curcumin alone, serum levels in humans were barely measurable; with 20 mg piperine, bioavailability was 2000% higher [5]. The study was small.
  • Micelles: In a crossover study with 23 healthy people (a single dose of 500 mg curcuminoids), liquid micellar curcumin was on average 185-fold better available than native curcumin (women 277-fold, men 114-fold); micronized powder 9-fold [2].
  • Lecithin phytosome (Meriva): Absorption was about 29-fold higher than the unformulated mixture, but according to the authors plasma levels remained low [3]. In another study the phytosome formulation was only 7.9-fold above standard; a formulation with a hydrophilic carrier reached 45.9-fold [6]. After adjusting for the ten-fold dose difference, Asher et al. found no difference in plasma AUC between a standard extract and a phosphatidylcholine extract [7].
  • Nanoparticles (Theracurmin): At 30 mg, AUC was 27-fold higher than with curcumin powder [4].
  • BCM-95 (curcuminoids with turmeric oil): 6.93-fold compared with normal curcumin, in a crossover pilot study [8].

What this means in practice

Ordinary spice powder and unformulated curcumin give only low blood levels. Formulated products increase measured absorption, but to different degrees, and the factors for the same type of formulation differ between studies. Which form is best cannot be derived from these data, because direct comparisons with clinical endpoints are missing. Manufacturers' directions for use apply.

Limits of the statement

These are mainly small, short studies with single doses in healthy people, some run by the developers of the tested formulation (e.g. Theracurmin). Higher absorption does not demonstrate a health benefit. Different formulations may have different safety profiles; with medical conditions or medication, the question belongs with a doctor.

Common follow-up questions

We found no absorption study of culinary turmeric powder itself; the data concern curcumin. Turmeric powder contained 3.14 % curcumin on average in one analysis (Tayyem et al., 2006) DOI. Unformulated curcumin is poorly absorbed: after 2 g, serum levels were undetectable or very low (Shoba et al., 1998) DOI. In studies with healthy volunteers, formulations were absorbed much better, about 7.9- to 45.9-fold (Jäger et al., 2014) DOI.

A single “best” formulation cannot be demonstrated. A review of 11 formulations with data from healthy volunteers found higher bioavailability than unformulated curcumin, over 100-fold for NovaSol, CurcuWin and LongVida (Jamwal, 2018) DOI. In individual studies, a phytosome was 7.9-fold and a formulation with a hydrophilic carrier 45.9-fold (Jäger et al., 2014) DOI; a lecithin formulation was 29-fold, yet plasma levels stayed below those needed in the laboratory to inhibit most anti-inflammatory targets (Cuomo et al., 2011) DOI. Higher absorption does not mean stronger effects.

For plain, unformulated curcumin, a meal with some fat makes sense: curcumin is fat-soluble, and a meal containing fat enhances absorption according to a review (Stohs et al., 2020) DOI. In studies with healthy volunteers, formulations with carrier substances were absorbed much better than unformulated curcumin, for example a lecithin formulation about 29-fold (Cuomo et al., 2011) DOI and liquid micelles about 185-fold compared with native curcuminoid powder (Schiborr et al., 2014) DOI. For supplements, follow the manufacturer's instructions.

Read more

Want to dive deeper into the subject? Continue here:

  • Intake guide: Worth knowing about bioavailability, modern formulations and the role of bioenhancers.
  • Safety check: A detailed look at safety, interactions and potential risks.
  • Effects overview: Answers to general questions about effects and application areas of the turmeric active ingredient.

References

  • [1] Anand, P. et al. (2007). Bioavailability of curcumin: problems and promises. Molecular Pharmaceutics. DOI: 10.1021/mp700113r
  • [2] Schiborr, C. et al. (2014). The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes. Molecular Nutrition & Food Research. DOI: 10.1002/mnfr.201300724
  • [3] Cuomo, J. et al. (2011). Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation. Journal of Natural Products. DOI: 10.1021/np1007262
  • [4] Sasaki, H. et al. (2011). Innovative preparation of curcumin for improved oral bioavailability. Biological and Pharmaceutical Bulletin. DOI: 10.1248/bpb.34.660
  • [5] Shoba, G. et al. (1998). Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Medica. DOI: 10.1055/s-2006-957450
  • [6] Jäger, R. et al. (2014). Comparative absorption of curcumin formulations. Nutrition Journal. DOI: 10.1186/1475-2891-13-11
  • [7] Asher, G. N. et al. (2016). Randomized pharmacokinetic crossover study comparing 2 curcumin preparations in plasma and rectal tissue of healthy human volunteers. The Journal of Clinical Pharmacology. DOI: 10.1002/jcph.806
  • [8] Antony, B. et al. (2008). A pilot cross-over study to evaluate human oral bioavailability of BCM-95CG (Biocurcumax), a novel bioenhanced preparation of curcumin. Indian Journal of Pharmaceutical Sciences. DOI: 10.4103/0250-474X.44591

Turmeric powder contains only about 2–6% curcuminoids [1, 2], on average 3.14% curcumin in pure powder [2]. Studies with curcuminoid products used 500–1,500 mg per day [3, 4]. No general intake recommendation can be derived from this.

In short
  • Curcuminoids in the powder: about 2–6% [1]; pure powder averaged 3.14% curcumin [2]
  • Content varies widely between products [2, 5]
  • Studies with products: 500–1,500 mg per day [3, 4]
  • Single doses up to 12 g were examined in small studies [6, 7]

What's behind it

Turmeric powder is a spice, not a standardized product. The dosing question therefore has two parts: how much curcumin is in the powder, and which amounts were examined in studies? A teaspoon delivers little curcumin depending on the powder, and the studies used extracts rather than culinary powder.

What the sources show

About 2–6% (w/w) of turmeric powder is curcuminoids [1]. An analysis of 28 spice products found an average of 3.14% curcumin in pure turmeric powder; curry powders mostly contained small and highly variable amounts [2]. An Indian market survey found 2.2–3.7% curcumin in branded powders and 0.3–2.6% in loose powders; 17% of the loose samples also contained the dye metanil yellow (not permitted under Indian food law) [5]. The rest of the powder is mainly carbohydrates (around 70%), plus water, protein, essential oils and fat [8].

A worked example: if a level teaspoon weighs roughly 2–3 g (kitchen rule of thumb), 3.14% gives a calculated 60–95 mg of curcumin. This is our own back-of-the-envelope calculation based on [2], not a measured value.

Clinical studies worked with different orders of magnitude: 500 mg curcuminoids per day with 5 mg piperine for three months in people with type 2 diabetes [3], or 1,500 mg of Curcuma domestica extract per day for four weeks in knee osteoarthritis [4]. The doses in these studies are not recommendations.

On tolerability of high single doses: in a dose-escalation study with 24 healthy volunteers (single doses of 500 to 12,000 mg of a standardized extract), 7 people had only minor complaints that did not appear dose-related. No curcumin was detected in serum up to 8,000 mg [6]. At single doses of 10 and 12 g, another study found mainly glucuronide and sulfate conjugates, with free curcumin in only one person [7]. Both studies used single doses, not daily intake.

The European Medicines Agency lists 0.5–1 g of powder, 2–3 times daily (adults), in its monograph for traditional herbal medicinal products. That is a figure for medicinal products, not an intake recommendation. Use is not recommended in gallstones and other biliary diseases, nor in pregnancy and breastfeeding because of insufficient data [9].

What this means in practice

As a spice in usual kitchen amounts, turmeric provides only small amounts of curcumin. Anyone wanting to take in curcumin in the amounts used in studies would calculate far larger quantities of powder. Standardized extracts can be dosed more consistently; the manufacturer's instructions apply.

Limits of the statement

The contents are averages from individual analyses and vary with origin and processing. Study doses come from particular groups, products and questions and cannot be transferred. There is no generally valid dose recommendation for turmeric powder. With medical conditions, medication, pregnancy or breastfeeding, the question belongs with a doctor.

Common follow-up questions

Pure turmeric powder averaged 3.14% curcumin by weight in an analysis of 28 products, while curry powders contained little and varied widely (Tayyem et al., 2006) DOI. By calculation (our assumption: a level teaspoon weighs about 2–3 g) this gives roughly 60–95 mg of curcumin per teaspoon. The actual content depends on the product.

As a spice turmeric belongs in the kitchen; as a supplement the powder is impractical: it averaged 3.14% curcumin in one analysis (Tayyem et al., 2006) DOI, so by calculation about 32 g of powder would be needed for 1 g of curcumin. In addition, curcumin's poor water solubility and bioavailability limit its use, which is why various formulations have been developed (Kotha et al., 2019) DOI. After 2 g of curcumin alone, serum levels in healthy volunteers were undetectable or very low (Shoba et al., 1998) DOI.

As a spice, turmeric is a common food: the US FDA classes it as generally recognised as safe (GRAS), and it is generally well tolerated; gastrointestinal side effects such as nausea and diarrhoea and allergic reactions have been reported (LactMed, 2025) PMID 30000906. No health claims can be derived from this. For use as a supplement, note that pure turmeric powder averaged only 3.14% curcumin in an analysis of 28 products, with curry powders much lower and highly variable (Tayyem et al., 2006) DOI.

According to the USDA database, a teaspoon of ground turmeric weighs 3.0 g (USDA FoodData Central, SR Legacy 172231) Link. The weight varies with grind and packing. Since turmeric powder contained on average about 3.1% curcumin (Tayyem et al., 2006) DOI, this works out to roughly 90 mg curcumin per teaspoon; this is a back-of-the-envelope calculation, not a measurement.

Read more

Want to dive deeper into the subject? Continue here:

  • Intake guide: Worth knowing about bioavailability, modern formulations and the role of bioenhancers.
  • Safety check: A detailed look at safety, interactions and potential risks.
  • Effects overview: Answers to general questions about effects and application areas of the turmeric active ingredient.

References

  • [1] Gupta, S. C., Patchva, S. & Aggarwal, B. B. (2013). Therapeutic roles of curcumin: lessons learned from clinical trials. The AAPS Journal. DOI: 10.1208/s12248-012-9432-8
  • [2] Tayyem, R. F. et al. (2006). Curcumin content of turmeric and curry powders. Nutrition and Cancer. DOI: 10.1207/s15327914nc5502_2
  • [3] Panahi, Y. et al. (2018). Effects of curcuminoids plus piperine on glycemic, hepatic and inflammatory biomarkers in patients with type 2 diabetes mellitus: a randomized double-blind placebo-controlled trial. Drug Research. DOI: 10.1055/s-0044-101752
  • [4] Kuptniratsaikul, V. et al. (2014). Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis: a multicenter study. Clinical Interventions in Aging. DOI: 10.2147/CIA.S58535
  • [5] Dixit, S. et al. (2009). Surveillance of the quality of turmeric powders from city markets of India on the basis of curcumin content and the presence of extraneous colours. Food Additives & Contaminants: Part A. DOI: 10.1080/02652030903016586
  • [6] Lao, C. D. et al. (2006). Dose escalation of a curcuminoid formulation. BMC Complementary and Alternative Medicine. DOI: 10.1186/1472-6882-6-10
  • [7] Vareed, S. K. et al. (2008). Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects. Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1055-9965.EPI-07-2693
  • [8] Kotha, R. R. & Luthria, D. L. (2019). Curcumin: biological, pharmaceutical, nutraceutical, and analytical aspects. Molecules. DOI: 10.3390/molecules24162930
  • [9] EMA/HMPC (2018). European Union herbal monograph on Curcuma longa L., rhizoma (EMA/HMPC/329755/2017), adopted 25 September 2018. https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-curcuma-longa-l-rhizoma-revision-1_en.pdf

Turmeric powder contains about 3–5% curcuminoids, of which roughly 77% is curcumin [1]. Pure powder averaged 3.14% curcumin [2], commercial goods 1.5–2.1% [3]. By calculation that is about 15–40 mg curcumin per gram of powder; extracts contain up to 95% curcuminoids [4].

Short answer
  • Curcuminoids in powder: about 3–5% [1, 5]
  • Curcumin share: around 77% of the curcuminoids [1]
  • Measured: 3.14% curcumin on average in pure powder [2]; 1.5–2.1% in Nepalese commercial powder [3]
  • Curcumin per gram of powder: about 15–40 mg by calculation (our calculation)
  • Other components: carbohydrates 60–70%, fat 5–10%, essential oil 3–7% [1]
  • Extracts: products with at least 95% curcuminoids are described [4, 6]

What lies behind it

The turmeric root (rhizome) is a complex natural product. Most of the dried powder is carbohydrate; curcuminoids are only a small share. They give the powder its orange-yellow colour, and the essential oils its aroma [1]. Turmerones are among the oil constituents [7].

What the sources show

Composition: A review gives for turmeric 6–13% moisture, 60–70% carbohydrate, 6–8% protein, 5–10% fat, 3–7% minerals and 3–7% essential oil [1]. Other reviews give similar values [5].

Curcuminoids: They make up about 3–5%. There are three compounds: curcumin (77%), demethoxycurcumin (17%) and bisdemethoxycurcumin (3–6%) [1].

Measured values: In 28 spice products, pure turmeric powder had the highest curcumin content, averaging 3.14% by weight; curry powder usually contained little, with wide scatter [2]. In Nepal, commercial powders contained 1.5–2.1% curcumin, samples made from fresh rhizomes up to 13.95% [3].

Calculation: With 3–5% curcuminoids and a 77% curcumin share, this gives 23–38 mg curcumin per gram of powder; with the measured mean of 3.14% curcumin it would be about 31 mg per gram. Including the lower commercial value of 1.5–2.1%, the overall range is roughly 15–40 mg per gram (our calculation, not a measurement). For comparison, 500 mg of curcumin would correspond to roughly 13–33 g of powder, an amount hardly usual as a spice.

Extracts: Purified powders with at least 95% curcuminoids are described and have been used in studies [4, 6]. A formulation combining curcuminoids with volatile oils of the rhizome raised absorption in healthy volunteers to only 1.3 times that of the standard extract [4].

What this means in practice

As a spice, turmeric powder provides flavour and colour but only small amounts of curcumin. Anyone who needs to know the curcumin amount precisely depends on standardised products with analysis; the content of spice powder varies considerably.

Limits of this statement

The contents are averages or individual measurements and depend on variety, origin, harvest and processing. Converting powder amounts into curcumin is an approximation. The answer describes constituents, not health effects or a dosing recommendation.

Frequently asked questions

According to a review, dried turmeric powder consists of roughly 70% carbohydrates, 13% moisture, 6% protein, 6% essential oils, 5% fat and 3% minerals; curcuminoids make up 3–5% (Kotha et al., 2019) DOI. These are approximate values that vary with variety and origin (Li et al., 2011) DOI.

With an average of 3.14% curcumin in pure turmeric powder (Tayyem et al., 2006) DOI, about 16 g of powder would be needed for 500 mg of curcumin (500 mg ÷ 0.0314). Content varies by product; the amount is a calculation, not a study value.

No. Curcuminoid shares of 2–6% (Gupta et al., 2013) DOI or 3–5% (Kotha et al., 2019) DOI are reported for turmeric; in an analysis of 28 products pure turmeric powder averaged 3.14% curcumin, while curry powders had far less and varied widely (Tayyem et al., 2006) DOI. Variety, origin and processing influence the content (Li et al., 2011) DOI.

A standardized extract used in a clinical study contained at least 95% curcuminoids (Lao et al., 2006) DOI, whereas pure turmeric powder averaged 3.14% curcumin (Tayyem et al., 2006) DOI. By calculation, 500 mg of curcuminoids correspond to about 0.5 g of extract instead of about 16 g of powder. Absorption of unformulated curcuminoids remains low; formulations can raise it (Cuomo et al., 2011) DOI.

Keep reading

  • Intake guide: Information on bioavailability, modern formulations and the role of bioenhancers.
  • Safety check: A detailed look at safety, interactions and potential risks.
  • Effects overview: Answers to general questions about effects and areas of use of the turmeric active ingredient.

References

  • [1] Zhang, H. A. & Kitts, D. D. (2021). Turmeric and its bioactive constituents trigger cell signaling mechanisms that protect against diabetes and cardiovascular diseases. Molecular and Cellular Biochemistry. DOI: 10.1007/s11010-021-04201-6
  • [2] Tayyem, R. F. et al. (2006). Curcumin content of turmeric and curry powders. Nutrition and Cancer. DOI: 10.1207/s15327914nc5502_2
  • [3] Paudel, D. et al. (2025). Optimization and validation of a new HPLC method for the comparative analysis of curcumin in fresh rhizome across Gandaki Province, Nepal, and marketed turmeric powder. Journal of Food Quality. DOI: 10.1155/jfq/8925770
  • [4] Jäger, R. et al. (2014). Comparative absorption of curcumin formulations. Nutrition Journal. DOI: 10.1186/1475-2891-13-11
  • [5] Kotha, R. R. & Luthria, D. L. (2019). Curcumin: Biological, Pharmaceutical, Nutraceutical, and Analytical Aspects. Molecules. DOI: 10.3390/molecules24162930
  • [6] Hewlings, S. J. & Kalman, D. S. (2017). Curcumin: a review of its effects on human health. Foods. DOI: 10.3390/foods6100092
  • [7] Singh, G. et al. (2010). Comparative study of chemical composition and antioxidant activity of fresh and dry rhizomes of turmeric (Curcuma longa Linn.). Food and Chemical Toxicology. DOI: 10.1016/j.fct.2010.01.015

In cooking, yes, though flavour and colour differ slightly. Fresh root is mostly water (about 79% in one study) [1], while powder contains roughly 3–5% curcuminoids [2, 3]. The literature gives no fixed conversion ratio.

Replacement tips
  • Fresh root contains a lot of water (78.65% in a drying study); powder only about 6–13% [1, 2]
  • Aroma: the essential oil of fresh and dried rhizomes differs in composition [4]
  • There is no validated conversion ratio from fresh to powder; add gradually and taste
  • Curcumin is poorly water-soluble; fat in a meal can raise absorption of a turmeric formulation [3, 5]

What lies behind it

In cooking, aroma, colour and availability matter. Fresh root and powder come from the same rhizome but differ in water content and processing. Curcuminoids give turmeric its orange-yellow colour, and the essential oils its aroma [2].

What the sources show

Water content: Fresh rhizomes had 78.65% moisture in a drying study, and still 5.5–6.4% after twelve hours of drying [1]. A review gives 6–13% moisture, 60–70% carbohydrate, 5–10% fat and 3–7% essential oil for dried turmeric [2]. Per gram, powder therefore contains considerably more dry matter than fresh root.

Curcuminoids in powder: Reviews give about 3–5% curcuminoids for turmeric, of which roughly 77% is curcumin [2, 3]. In 28 spice products, pure turmeric powder averaged 3.14% curcumin, while curry powders were clearly lower and highly variable [6]. In a Nepalese study, powders made from fresh rhizomes contained up to 13.95% curcumin, commercial powders 1.5–2.1% [7]. The range shows how strongly origin and processing affect content. Drying matters too: at 57 °C and low humidity, curcumin yield was highest among the non-blanched samples [8].

Fresh versus dried: The essential oil differs: α-turmerone was a main component of the oil from fresh rhizomes but only a minor one in dried rhizomes. Oil and oleoresin from fresh rhizomes showed stronger antioxidant properties in laboratory assays [4]. These are laboratory findings and say nothing about effects in humans.

Absorption: Curcumin is poorly water-soluble, which limits its absorption [3]. With a highly bioavailable turmeric formulation, absorption was higher in lipid-containing foods such as an oat drink (+76% AUC) [5]. After meals of turmeric powder with black pepper, a small preliminary study found more curcumin excreted in urine (218 versus 49 µg in 24 hours) [9].

What this means in practice

In cooking, fresh turmeric can be replaced with powder when it is not at hand. Because fresh root contains a lot of water, powder is considerably more concentrated per gram. No tested conversion ratio exists, so start with less powder and taste. Aroma and colour will turn out slightly different. A meal containing fat suits most dishes anyway.

Limits of this statement

The contents are measurements of individual samples and vary with variety, origin and processing. The absorption studies involved one formulation or a small group of volunteers and cannot simply be transferred to fresh root or powder. This answer describes kitchen practice and constituents, not health effects. If you use turmeric as a food supplement, follow the product label.

Frequently asked questions

Whether fresh turmeric acts differently in the body than powder has, to our knowledge, not been compared in human studies. What can be measured is the water content: fresh rhizomes had just under 79% water in a drying study (Borah et al., 2015) DOI. Pure turmeric powder contained on average 3.14% curcumin by weight (Tayyem et al., 2006) DOI. Fresh and dried rhizomes also differ in their aroma compounds, and oil and oleoresin from fresh rhizomes showed higher antioxidant activity in laboratory tests (Singh et al., 2010) DOI. No effect in humans can be derived from this.

Culinarily this is possible, but quantities and aroma differ. In a drying study, fresh rhizomes had a water content of just under 79%, falling to about 5.5–6.4% after drying (Borah et al., 2015) DOI; powder is therefore much more concentrated per gram. The aroma compounds also differ: α-turmerone, a main component of the oil of fresh rhizomes, is only a minor component in dried ones (Singh et al., 2010) DOI. We found no fixed conversion factor in studies; it is best to approach the amount step by step.

To our knowledge there is no fixed conversion. Fresh rhizome is just under 79% water (Borah et al., 2015) DOI, while turmeric powder contained on average 3.14% curcumin (Tayyem et al., 2006) DOI. Extracts, by contrast, are adjusted to specific curcuminoid contents that differ from product to product and are stated on the label. Content also says nothing about absorption: in a crossover study in healthy people, total curcuminoid absorption from a lecithin formulation was about 29-fold higher than from an unformulated curcuminoid mixture (Cuomo et al., 2011) DOI.

Further reading

Want to go deeper into the subject? Here is where to continue:

  • Intake guide: Everything about bioavailability, modern formulations and the role of bioenhancers.
  • Effects overview: Answers to general questions about effects and areas of use of the turmeric active ingredient.
  • Safety check: A detailed look at safety, interactions and potential risks.

References

  • [1] Borah, A. et al. (2015). Drying kinetics of whole and sliced turmeric rhizomes (Curcuma longa L.) in a solar conduction dryer. Information Processing in Agriculture. DOI: 10.1016/j.inpa.2015.06.002
  • [2] Zhang, H. A. & Kitts, D. D. (2021). Turmeric and its bioactive constituents trigger cell signaling mechanisms that protect against diabetes and cardiovascular diseases. Molecular and Cellular Biochemistry. DOI: 10.1007/s11010-021-04201-6
  • [3] Kotha, R. R. & Luthria, D. L. (2019). Curcumin: Biological, Pharmaceutical, Nutraceutical, and Analytical Aspects. Molecules. DOI: 10.3390/molecules24162930
  • [4] Singh, G. et al. (2010). Comparative study of chemical composition and antioxidant activity of fresh and dry rhizomes of turmeric (Curcuma longa Linn.). Food and Chemical Toxicology. DOI: 10.1016/j.fct.2010.01.015
  • [5] Schönenberger, K. A. et al. (2025). The influence of food matrices on the bioavailability of curcuminoids from a dried colloidal turmeric suspension: a randomized, crossover, clinical trial. Food & Function. DOI: 10.1039/d4fo03414g
  • [6] Tayyem, R. F. et al. (2006). Curcumin content of turmeric and curry powders. Nutrition and Cancer. DOI: 10.1207/s15327914nc5502_2
  • [7] Paudel, D. et al. (2025). Optimization and validation of a new HPLC method for the comparative analysis of curcumin in fresh rhizome across Gandaki Province, Nepal, and marketed turmeric powder. Journal of Food Quality. DOI: 10.1155/jfq/8925770
  • [8] Gan, H. et al. (2016). Effects of drying and blanching on the retention of bioactive compounds in ginger and turmeric. Horticulturae. DOI: 10.3390/horticulturae3010013
  • [9] Khajehpour, S. et al. (2023). Development of a rapid, sensitive, and selective LC-MS/MS method for quantifying curcumin levels in healthy human urine: effect of pepper on curcumin bioavailability. Food Science & Nutrition. DOI: 10.1002/fsn3.3691

Technically yes, but turmeric powder contains only about 2–6% curcuminoids [1], on average 3.14% curcumin [2]. A capsule with 0.5 g of powder holds a calculated 16 mg of curcumin. There are no studies on self-filled capsules.

DIY capsules vs. extract
  • Powder: about 2–6% curcuminoids [1], average 3.14% [2]
  • Content varies widely between powders [3]
  • Standardized extracts: at least 95% curcuminoids [4]
  • Native curcumin is poorly absorbed [5, 6]

What's behind it

Filling empty capsules with turmeric powder is technically simple. What matters is what you end up with: spice powder is not a standardized product, and curcumin is a compound that is poorly absorbed.

What the sources show

Content. Curcuminoids make up about 2–6% (w/w) of turmeric powder [1]. An analysis of 28 spice products found an average of 3.14% curcumin in pure turmeric powder; curry powders mostly contained small and highly variable amounts [2]. A survey of Indian market samples found 2.2–3.7% in branded and 0.3–2.6% in loose powders; 17% of the loose samples were adulterated with the dye metanil yellow, and the low content might be due to admixture of other Curcuma species or foreign starch [3]. The main component of the powder is carbohydrates (around 70%) [7].

For comparison, one study examined a standardized extract with at least 95% curcuminoids in capsules [4]. A capsule with 0.5 g of powder contains, at 3.14%, a calculated 16 mg of curcumin. This is our own back-of-the-envelope calculation based on [2], and the fill amount is assumed. In a study in type 2 diabetes, the dose was 500 mg curcuminoids per day (together with 5 mg piperine) [8]. The number of capsules needed to reach that amount with spice powder would be calculated at around 30 per day; this is not a recommendation.

Absorption. Curcumin is poorly absorbed, rapidly metabolized and eliminated [6]. After a single dose of 500 mg curcuminoids as native powder, blood levels were low compared with formulated versions; liquid micelles reached on average 185-fold [5]. Whether spice powder in capsules provides relevant levels at all has, to our knowledge, not been studied.

Traditional use. The EMA lists 0.5–1 g of powder, 2–3 times daily (adults), for traditional herbal medicinal products; this is not a recommendation for filling capsules yourself. Use is not recommended in biliary disease and gallstones, nor in pregnancy and breastfeeding [9].

What this means in practice

Self-filled spice powder gives little curcumin per capsule, with an unknown content, and has not been tested in studies. Standardized products state the curcuminoid content; the studies behind statements about curcumin used such extracts. With self-made capsules you are responsible for dosing, hygiene and the quality of the ingredient.

Limits of the statement

There is no study on self-filled capsules; the statements are derived from analyses of powders and from studies with extracts. The Indian figures apply to samples from that market. With medical conditions, medication, pregnancy or breastfeeding, please seek medical advice.

Common follow-up questions

The notification duty does not apply to your own use, as it concerns manufacturers and importers: anyone who wants to place a food supplement on the market must notify the Federal Office of Consumer Protection and Food Safety (BVL) at the latest at first marketing, with a label sample (NemV § 5). If you pass products to others, further food-law obligations apply; when in doubt, ask your local food control authority.

Ready-made products can differ markedly from plain powder in absorption: in crossover studies in healthy volunteers, curcuminoid uptake of formulated products was 7.9 to 45.9 times (Jäger et al., 2014) DOI or about 29 times (Cuomo et al., 2011) DOI that of unformulated curcumin. The curcumin content of spice powders varies (turmeric 3.14% on average, curry powders low and variable) (Tayyem et al., 2006) DOI; in South Asia, turmeric was in part adulterated with lead chromate (Forsyth et al., 2024) DOI.

For your own use this is technically possible; absorption is one issue: a plain standardised curcuminoid mixture was absorbed markedly less than its lecithin formulation in a crossover study (about 29-fold lower total curcuminoid uptake) (Cuomo et al., 2011) DOI; similar for other formulations (Jäger et al., 2014) DOI. Anyone who passes on or sells capsules must notify them as food supplements (NemV § 5). Take care with hygiene and accurate dosing.

Further reading

Want to go deeper into the subject? Here is where to continue:

  • Intake guide: Everything about bioavailability, modern formulations and the role of bioenhancers.
  • Safety check: A detailed look at safety, interactions and potential risks.
  • Effects overview: Answers to general questions about effects and areas of use of the turmeric active ingredient.

References

  • [1] Gupta, S. C., Patchva, S. & Aggarwal, B. B. (2013). Therapeutic roles of curcumin: lessons learned from clinical trials. The AAPS Journal. DOI: 10.1208/s12248-012-9432-8
  • [2] Tayyem, R. F. et al. (2006). Curcumin content of turmeric and curry powders. Nutrition and Cancer. DOI: 10.1207/s15327914nc5502_2
  • [3] Dixit, S. et al. (2009). Surveillance of the quality of turmeric powders from city markets of India on the basis of curcumin content and the presence of extraneous colours. Food Additives & Contaminants: Part A. DOI: 10.1080/02652030903016586
  • [4] Lao, C. D. et al. (2006). Dose escalation of a curcuminoid formulation. BMC Complementary and Alternative Medicine. DOI: 10.1186/1472-6882-6-10
  • [5] Schiborr, C. et al. (2014). The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes. Molecular Nutrition & Food Research. DOI: 10.1002/mnfr.201300724
  • [6] Anand, P. et al. (2007). Bioavailability of curcumin: problems and promises. Molecular Pharmaceutics. DOI: 10.1021/mp700113r
  • [7] Kotha, R. R. & Luthria, D. L. (2019). Curcumin: biological, pharmaceutical, nutraceutical, and analytical aspects. Molecules. DOI: 10.3390/molecules24162930
  • [8] Panahi, Y. et al. (2018). Effects of curcuminoids plus piperine on glycemic, hepatic and inflammatory biomarkers in patients with type 2 diabetes mellitus: a randomized double-blind placebo-controlled trial. Drug Research. DOI: 10.1055/s-0044-101752
  • [9] EMA/HMPC (2018). European Union herbal monograph on Curcuma longa L., rhizoma (EMA/HMPC/329755/2017), adopted 25 September 2018. https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-curcuma-longa-l-rhizoma-revision-1_en.pdf

Colour alone cannot verify turmeric: powder has been coloured yellow with lead chromate [1, 2], and a review estimated that 16.5% of the turmeric samples examined were adulterated or mislabelled [3]. Genuine powder averages about 3% curcumin [4]; laboratory analysis is the reliable check.

Quality check
  • Vivid colour is no proof of authenticity: lead chromate was added as a yellow pigment [1]
  • Typical curcumin content of pure powder: 3.14% on average [4]
  • For supplements, only 4 of 14 products matched their all-natural label in one sample [5]
  • Additives can be reliably identified only in the laboratory, not in the kitchen [6]

What lies behind it

Turmeric is traded by colour: curcuminoids colour the powder orange-yellow [7]. That is exactly what makes additives attractive that fake colour or stretch the raw material.

What the sources show

Prevalence: A review evaluated 78 publications; of 1,247 turmeric (root or rhizome) samples, 16.5% were adulterated or mislabelled. Products sold as licensed or registered herbal medicines were less often affected than food supplements; the authors stress the limited data [3].

Lead chromate: In Bangladesh, yellow lead chromate pigment was added when polishing dried roots, because consumers prefer bright yellow curry and traders could thus sell poor-quality roots. Turmeric powder with up to 1,152 µg/g lead was measured [1]. In a study across India, Pakistan, Sri Lanka and Nepal, 14% of 356 samples had detectable lead above 2 µg/g; in some cities values exceeded 1,000 µg/g [2].

Other additives: Reported adulterants include the dye Sudan Red G and the related plant Curcuma zedoaria ("white turmeric"); in the laboratory they could be detected by infrared spectroscopy [6].

Content: Pure turmeric powder averaged 3.14% curcumin, curry powders clearly less [4]. A typical curcuminoid content is given as 3–5% [7]. A conspicuously low or high value alone does not prove adulteration, because origin and processing vary widely.

Supplements: Among 14 products with turmeric ingredients, only four supported the "natural" claim; a high share of curcumin among the curcuminoids pointed to synthetic curcumin [5].

What this means in practice

Colour alone says little about purity; an especially bright yellow can even be a warning sign. Choose suppliers who name the origin and provide analyses for heavy metals and curcuminoids, and be cautious with conspicuously cheap goods. For powder without origin and batch information, neither lead nor curcumin content can be judged, however authentic the colour looks. We found no validated home tests (for example a glass of water) in the literature.

Limits of this statement

The prevalence figures come from different studies with unequal methods and markets and cannot be transferred to German retail goods. The spectroscopy studies used deliberately spiked laboratory samples. This answer contains no instructions for testing at home.

Frequently asked questions

Owing to high demand, economically motivated adulteration and contamination of turmeric powder has increased. Described are the dye metanil yellow (Dhakal et al., 2016) DOI, and Sudan Red G dye and white turmeric (Curcuma zedoaria) as additives (Dhakal et al., 2019) DOI. Lead chromate is a vibrant yellow, toxic and carcinogenic compound (Erasmus et al., 2020) DOI. A strong colour is therefore no proof of quality.

Appearance alone is not a reliable authenticity test. Curcumin is an orange-yellow pigment (Kocaadam & Şanlier, 2015) DOI, but colour is exactly what gets faked: vibrant yellow additives such as lead chromate have been found in turmeric, and the more vibrant a product, the higher its perceived quality (Erasmus et al., 2020) DOI. Adulteration with metanil yellow can only be detected with laboratory methods (spectroscopy), in that study from 1% (FT-Raman) or 5% (FT-IR) admixture (Dhakal et al., 2016) DOI. Look for suppliers that provide test certificates.

Turmeric powder is sold in supermarkets, drugstores and specialist shops. A brand name is no guarantee: adulteration and contamination of turmeric powder have increased with high demand (Dhakal et al., 2019) DOI, and a vibrant colour can be misleading (Erasmus et al., 2020) DOI. Ask for certificates of analysis, for example on curcumin content and contaminants, and prefer suppliers that disclose origin and testing.

Further reading

You want to go deeper into the subject? Here's where to go next:

  • Intake guide: Everything worth knowing about bioavailability, modern formulations and the role of bioenhancers.
  • Effects overview: Answers to general questions about effects and areas of use of the turmeric active ingredient.
  • Safety check: A detailed look at safety, interactions and potential risks.

References

  • [1] Forsyth, J. E. et al. (2019). Turmeric means “yellow” in Bengali: lead chromate pigments added to turmeric threaten public health across Bangladesh. Environmental Research. DOI: 10.1016/j.envres.2019.108722
  • [2] Forsyth, J. E. et al. (2024). Evidence of turmeric adulteration with lead chromate across South Asia. Science of The Total Environment. DOI: 10.1016/j.scitotenv.2024.175003
  • [3] Orhan, N. et al. (2024). Estimating the extent of adulteration of the popular herbs black cohosh, echinacea, elder berry, ginkgo, and turmeric – its challenges and limitations. Natural Product Reports. DOI: 10.1039/d4np00014e
  • [4] Tayyem, R. F. et al. (2006). Curcumin content of turmeric and curry powders. Nutrition and Cancer. DOI: 10.1207/s15327914nc5502_2
  • [5] You, H. et al. (2021). Analytical strategies to determine the labelling accuracy and economically-motivated adulteration of “natural” dietary supplements in the marketplace: turmeric case study. Food Chemistry. DOI: 10.1016/j.foodchem.2021.131007
  • [6] Dhakal, S. et al. (2019). Detection of additives and chemical contaminants in turmeric powder using FT-IR spectroscopy. Foods. DOI: 10.3390/foods8050143
  • [7] Zhang, H. A. & Kitts, D. D. (2021). Turmeric and its bioactive constituents trigger cell signaling mechanisms that protect against diabetes and cardiovascular diseases. Molecular and Cellular Biochemistry. DOI: 10.1007/s11010-021-04201-6

In studies with healthy people, micelles (185-fold [1]), cyclodextrin complexes (30–39-fold [2, 3]), nanoparticles (27-fold [4]) and phytosomes (29-fold [5]) increased curcumin uptake. For piperine the findings are inconsistent [6, 7].

Short answer
  • Native curcumin: after 2 g of powder, serum levels undetectable or very low [6]
  • Micelles: 185-fold AUC [1], 57-fold in another study [2]
  • Cyclodextrin complex: 30-fold [2] to 39-fold [3]
  • Nanoparticles (Theracurmin): 27-fold AUC [4]
  • Phytosome (Meriva): 29-fold [5]; 7.9-fold in another study [8], no significant rise in a third [2]
  • Piperine: 20-fold in one study [6], no difference in another [7]

What lies behind it

The low uptake of curcumin has two main causes: poor solubility and rapid metabolism in the liver and intestinal wall [6]. Almost only conjugated curcumin is found in blood [2]. Reviews list strategies including piperine, micelles, nanoparticles, liposomes and phospholipid complexes [9].

What the sources show

Baseline: After 2 g of curcumin, serum levels in healthy people were undetectable or very low [6]. In patient studies, levels were 0.51–1.77 µM after 4–8 g [10] and in the 10 nmol/L range with up to 3.6 g daily [11].

Micelles: Schiborr et al. found a 185-fold higher AUC than native powder in 23 healthy people after 500 mg of curcuminoids [1]. Flory et al. (12 healthy people, 207 mg) found 57-fold [2].

Cyclodextrin: The gamma-cyclodextrin complex raised the AUC 30-fold [2] and 39-fold [3] (12 healthy people each).

Nanoparticles: The colloidal nanoparticle dispersion Theracurmin had a 27-fold higher AUC than curcumin powder in healthy volunteers (30 mg) [4].

Phytosomes: The lecithin formulation Meriva showed 29-fold higher total absorption [5]. Another phytosome product reached 7.9-fold [8], and in Flory et al. the rise was not significant [2]. Results therefore depend strongly on the product.

Piperine: With 20 mg piperine, the bioavailability of 2 g curcumin rose by 2000% in a study with volunteers [6]. In a study of 30 healthy people, a piperine-curcuminoid combination did not differ significantly from the standard extract [7]; piperine also had no significant effect in Flory et al. [2]. In the laboratory, piperine inhibits the drug-metabolising enzyme CYP3A4 and P-glycoprotein, so interactions with medicines are possible [12].

Liposomes: They did not raise the AUC significantly in the comparison study [2].

What this means in practice

The formulation strongly influences how much curcumin reaches the blood. Micelles and cyclodextrin complexes showed the largest effects in the comparison studies. The factors apply to the product tested, not to the whole class. If you take medication regularly, have products containing piperine checked by a doctor first.

Limits of this statement

The increase factors come from single-dose studies in small groups of healthy volunteers and cannot be transferred to other brands or groups. Mostly conjugated curcuminoids were measured. Higher blood levels are no proof of a health benefit. This answer describes technological options and gives no dosing or therapy recommendation.

Frequently asked questions

This can only be compared with limits, since studies use different reference products and doses. In a crossover study in healthy volunteers (single 500 mg curcuminoids), liquid micellar curcumin was on average 185-fold better available than native powder across all subjects, micronized powder 9-fold (Schiborr et al., 2014) DOI. In another study, a formulation with a hydrophilic carrier reached 45.9-fold and a phytosome 7.9-fold the unformulated standard (Jäger et al., 2014) DOI. The micelle scored highest in these studies.

No, they differ greatly. In a randomised, double-blind crossover study in healthy volunteers, curcuminoids appeared in the blood 1.3-fold, 7.9-fold and 45.9-fold higher with three formulations than with an unformulated standard curcumin (Jäger et al., 2014) DOI. Absorption therefore depends on the formulation; the starting point is curcumin's poor solubility, low absorption and rapid elimination (Jäger et al., 2014) DOI.

In a study in healthy volunteers, piperine increased the bioavailability of 2 g curcumin by 2000% (Shoba et al., 1998) DOI. It is controversial because it also inhibits drug-metabolising enzymes: in laboratory tests with human enzymes, piperine was a relatively selective CYP3A inhibitor (Volak et al., 2008) DOI. A review describes interactions with several drugs, mostly increasing drug availability, and advises caution with isolated piperine (Ziegenhagen et al., 2021) DOI.

We found no head-to-head comparison of the two in one study. Individual studies: liquid micellar curcumin was on average 185-fold better available than native powder in healthy volunteers (Schiborr et al., 2014) DOI; a nano-liposomal curcumin reached a 23.2-fold higher dose-normalised AUC than free curcumin in 18 healthy men (Kim et al., 2026) DOI. These studies differ in design, dose and reference and cannot be set directly against each other.

Pharmacokinetic studies take blood samples over hours after intake and measure the concentration. In one crossover study in healthy volunteers, blood and urine samples were collected over 24 hours and the area under the plasma concentration-time curve (AUC) was compared (Schiborr et al., 2014) DOI. In a crossover design the same people take the formulations one after another, so they can be compared directly (Jäger et al., 2014) DOI.

Further reading

  • Intake guide: Bioavailability, modern formulations and the role of bioenhancers.
  • Safety check: A detailed look at safety, interactions and potential risks.
  • Effects overview: General questions about the areas of use studied.
  • Joint focus: The role of inflammatory processes in osteoarthritis and joint complaints.

References

  • [1] Schiborr, C. et al. (2014). The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes. Molecular Nutrition & Food Research. DOI: 10.1002/mnfr.201300724
  • [2] Flory, S. et al. (2021). Increasing post-digestive solubility of curcumin is the most successful strategy to improve its oral bioavailability: a randomized cross-over trial in healthy adults and in vitro bioaccessibility experiments. Molecular Nutrition & Food Research. DOI: 10.1002/mnfr.202100613
  • [3] Purpura, M. et al. (2018). Analysis of different innovative formulations of curcumin for improved relative oral bioavailability in human subjects. European Journal of Nutrition. DOI: 10.1007/s00394-016-1376-9
  • [4] Sasaki, H. et al. (2011). Innovative preparation of curcumin for improved oral bioavailability. Biological and Pharmaceutical Bulletin. DOI: 10.1248/bpb.34.660
  • [5] Cuomo, J. et al. (2011). Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation. Journal of Natural Products. DOI: 10.1021/np1007262
  • [6] Shoba, G. et al. (1998). Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Medica. DOI: 10.1055/s-2006-957450
  • [7] Fança-Berthon, P. et al. (2021). Pharmacokinetics of a single dose of turmeric curcuminoids depends on formulation: results of a human crossover study. The Journal of Nutrition. DOI: 10.1093/jn/nxab087
  • [8] Jäger, R. et al. (2014). Comparative absorption of curcumin formulations. Nutrition Journal. DOI: 10.1186/1475-2891-13-11
  • [9] Hegde, M. et al. (2023). Curcumin formulations for better bioavailability: what we learned from clinical trials thus far?. ACS Omega. DOI: 10.1021/acsomega.2c07326
  • [10] Cheng, A. L. et al. (2001). Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Research. PMID: 11712783
  • [11] Sharma, R. A. et al. (2004). Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clinical Cancer Research. DOI: 10.1158/1078-0432.CCR-04-0744
  • [12] Bhardwaj, R. K. et al. (2002). Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4. Journal of Pharmacology and Experimental Therapeutics. DOI: 10.1124/jpet.102.034728

In micellar curcumin, curcumin is embedded in tiny droplets. In single-dose studies in healthy people, uptake (AUC) was 57- to 185-fold higher than with native curcumin, depending on the product [1, 2]. This says nothing about health effects.

Short answer
  • Micelles are tiny droplets with a water-friendly shell and a fat-friendly core
  • In studies, the AUC was 57-fold [1] to 185-fold [2] higher than native curcumin (depending on study and product)
  • In one comparison, dose-normalised 136 versus 3.7 ng·h/mL/mg for the standard extract [3]
  • All studies: single dose, healthy adults
  • Higher blood levels are no proof of a health benefit

What lies behind it

Native curcumin is poorly water-soluble and is absorbed only to a small extent [1]. In micellar preparations, curcumin is enclosed in tiny structures with a water-friendly outside so that it dissolves better in the watery environment of the digestive tract. The researchers attribute the better uptake of micellar curcumin to higher stability and solubility after digestion [1].

What the sources show

Schiborr et al. studied 23 healthy people (13 women, 10 men) in a crossover design. In random order they took a single dose of 500 mg curcuminoids as native powder, micronised powder or liquid micelles. The AUC of micellar curcumin was 185-fold higher than native curcumin across all subjects (277-fold in women, 114-fold in men). Women absorbed curcumin more efficiently than men. All safety parameters stayed within the reference range [2].

Flory et al. compared eight formulations after a single dose of 207 mg curcumin in a randomised crossover trial with 12 healthy adults. Only micelles (57-fold) and the gamma-cyclodextrin complex (30-fold) raised the AUC significantly. Liposomes, phytosomes and piperine additives gave no significant increase. Only conjugated, no free curcumin was found in blood [1].

Fança-Berthon et al. gave 30 healthy adults single doses of different preparations. The liquid micellar preparation delivered the highest total curcuminoid levels; dose-normalised, the AUC was 136 versus 3.7 ng·h/mL/mg for the standard extract [3]. A review of eleven formulations lists NovaSol with 185-fold bioavailability compared with unformulated curcumin [4].

The gap between 57-fold and 185-fold is probably due to different products, doses, reference preparations and study designs; the studies do not allow a direct comparison.

What this means in practice

In studies, micellar curcumin leads to markedly higher plasma levels of measured curcuminoids than native curcumin. When choosing a preparation, the formulation is therefore a relevant criterion if absorption matters. Higher levels do not, however, automatically mean a health benefit.

Limits of this statement

The values come from single-dose studies in healthy volunteers, and participant numbers are small. Transfer to other groups, long-term use or health questions has not been shown. The figures are product-specific and can vary with the carrier material. The studies mainly measured conjugated metabolites, not free curcumin. This answer does not replace medical advice.

Frequently asked questions

In these two studies, yes: AUC was 57-fold (12 healthy adults, 207 mg; Flory et al., 2021) DOI or 185-fold (23 healthy adults, 500 mg; Schiborr et al., 2014) DOI higher than with native curcumin. These were single doses in healthy people; they say nothing about health effects.

No direct study addresses this. Micellar curcumin was more soluble and stable after digestion than other formulations (Flory et al., 2021) DOI. For curcuminoids in food matrices, absorption was higher with lipids (Schönenberger et al., 2025) DOI. Whether fat further improves absorption of micellar curcumin was not tested in these studies.

In the study by Flory et al. (12 healthy adults, single dose of 207 mg curcumin), micelles reached a 57-fold higher AUC than native curcumin; preparations with adjuvants such as piperine showed no significant increase (Flory et al., 2021) DOI.

They are different approaches: micelles enclose curcumin, phytosomes bind it to phospholipids. In the crossover study by Flory et al., only micelles (57-fold) and the γ-cyclodextrin complex (30-fold) significantly increased AUC versus native curcumin; phytosomes did not (Flory et al., 2021) DOI. In another study, phytosome absorption was 7.9-fold higher (Jäger et al., 2014) DOI.

In a crossover study of 23 healthy adults, all safety parameters measured stayed within reference ranges after a single dose of 500 mg curcuminoids as liquid micelles (Schiborr et al., 2014) DOI. This applies to a single dose; the study provides no data on long-term use. How you tolerate it is individual.

Further reading

  • Intake guide: Bioavailability, modern formulations and the role of bioenhancers.
  • Safety check: Safety, interactions and potential risks.
  • Effects overview: General questions about areas of use of the turmeric active ingredient.
  • Joint focus: The role of inflammatory processes in osteoarthritis and joint complaints.

References

  • [1] Flory, S. et al. (2021). Increasing post-digestive solubility of curcumin is the most successful strategy to improve its oral bioavailability: a randomized cross-over trial in healthy adults and in vitro bioaccessibility experiments. Molecular Nutrition & Food Research. DOI: 10.1002/mnfr.202100613
  • [2] Schiborr, C. et al. (2014). The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes. Molecular Nutrition & Food Research. DOI: 10.1002/mnfr.201300724
  • [3] Fança-Berthon, P. et al. (2021). Pharmacokinetics of a single dose of turmeric curcuminoids depends on formulation: results of a human crossover study. The Journal of Nutrition. DOI: 10.1093/jn/nxab087
  • [4] Jamwal, R. (2018). Bioavailable curcumin formulations: a review of pharmacokinetic studies in healthy volunteers. Journal of Integrative Medicine. DOI: 10.1016/j.joim.2018.07.001

Liposomal turmeric encloses curcumin in phospholipid vesicles to improve its poor absorption [1]. In a small study of 18 healthy men, dose-normalized absorption was 23-fold higher than with free curcumin [2].

In short
  • Liposomes: tiny phospholipid vesicles in which curcumin is embedded [1]
  • Human study (n = 18, single dose): dose-normalized AUC 23.2-fold higher than free curcumin [2]
  • Liquid micelles: 185-fold vs. native curcumin, different study [3]
  • The studies are not directly comparable

What's behind it

Curcumin is fat-soluble, poorly absorbed, rapidly metabolized and quickly eliminated [1]. One of the approaches examined is the liposomal preparation: curcumin is enclosed in liposomes, small vesicles with a shell of phospholipids [1]. Liposomes are also studied as carriers of other active ingredients; here we only look at the oral absorption of curcumin.

What the sources show

Liposomal curcumin. Human data are thin. In a randomized, double-blind, parallel-group study, 18 healthy men (9 per group) received a single dose under fasting conditions of either a nano-liposomal product (400 mg curcumin equivalent, coated with chitosan/alginate) or free curcumin (2,000 mg). Dose-normalized, the area under the concentration-time curve (AUC) was 23.2-fold and the peak 53-fold higher; the peak occurred earlier (0.86 vs. 3.3 hours). The product was well tolerated as a single dose. The authors call the results a proof of concept that justifies further clinical investigation [2].

Other formulations. For liquid micelles, a crossover study with 23 healthy people (500 mg curcuminoids as a single dose) showed on average 185-fold higher availability (AUC) than native curcumin; micronized powder reached 9-fold [3]. A lecithin phytosome, which is a related but not liposomal system, increased total absorption about 29-fold over the unformulated mixture in a crossover study, though according to the authors plasma levels remained low [4].

Whether liposomal curcumin or micelles reach higher levels cannot be told from these numbers: the studies differ in dose, comparator, participants, analysis (dose-normalized or not) and product. We did not find a direct head-to-head study in humans.

What this means in practice

Liposomal products are one approach to improving curcumin absorption. What is shown so far is higher absorption in one small study in healthy men with one specific product. Whether and how this translates into health effects has not been examined. Products differ in manufacture and composition; curcumin content and serving size are stated by the manufacturer.

Limits of the statement

The evidence on orally taken liposomal curcumin here rests on a single small single-dose study. Some figures are dose-normalized, others are not. Anyone with biliary disease or gallstones should use turmeric preparations only after medical advice; the EMA monograph advises against use in these cases [5]. The same applies to pregnancy and breastfeeding, where the data are insufficient [5].

Common follow-up questions

In a comparison trial in 12 healthy adults (single dose of 207 mg curcumin), micelles raised absorption 57-fold over native curcumin, whereas liposomes did not raise it significantly (Flory et al., 2021) DOI. In another study (500 mg curcuminoids), micelles reached 185 times the native form (Schiborr et al., 2014) DOI. These studies give no details on the carriers' structure.

There is no evidence for it. In a randomized trial of 12 healthy adults (single dose of 207 mg curcumin), only micelles (57-fold) and a γ-cyclodextrin complex (30-fold) raised absorption significantly; liposomes and the combination with adjuvants including piperine did not (Flory et al., 2021) DOI. Strategies that inhibit breakdown appeared ineffective there.

There is no reliable source on this. Cyclomaltooctaose (γ-cyclodextrin) is a carrier system in its own right; in a study of 12 healthy adults the γ-cyclodextrin complex raised absorption 30-fold, liposomes not significantly (Flory et al., 2021) DOI. Another study also found improved absorption with a γ-cyclodextrin formulation (Purpura et al., 2017) DOI.

Read more

Want to go deeper into the subject? Here is where to continue:

  • Intake guide: Useful information on bioavailability, modern formulations and the role of bioenhancers.
  • Safety check: A detailed look at safety, interactions and potential risks.
  • Effects overview: Answers to general questions about the effects and areas of use of the turmeric active ingredient.

References

C3 Complex is a brand name (Sabinsa) for a standardized turmeric extract with at least 95% of the three curcuminoids [1]. Turmeric as a spice contains only about 2–6% curcuminoids [2]. Claims about the extract's effects cannot be derived from these sources.

In short
  • C3 Complex: standardized extract, at least 95% curcuminoids [1]
  • Three curcuminoids: curcumin, demethoxycurcumin, bisdemethoxycurcumin [1]
  • Analyzed capsules: 75% curcumin, 23% demethoxycurcumin, 2% bisdemethoxycurcumin [1]
  • Turmeric rhizome in general: about 77 : 17 : 3–6 [3]

What's behind it

"Curcumin C3 Complex" is the trade name of a turmeric extract from the manufacturer Sabinsa. It refers to a standardized extract that consists almost entirely of the three natural curcuminoids, not the whole spice powder. The term therefore describes a composition, not a particular effect.

What the sources show

In one study, C3 Complex was described as a capsule powder from Alleppey turmeric containing at least 95% of the three curcuminoids curcumin, bisdemethoxycurcumin and demethoxycurcumin [1]. In chemical analysis of the capsules, the authors found 75% curcumin, 23% demethoxycurcumin and 2% bisdemethoxycurcumin, and noted this was consistent with other commercial curcuminoid products. The HPLC signal for curcumin in a weighed portion of the capsule content was also 66% lower than in an equal portion of a previously supplied pure curcumin powder (unpublished data, per the authors); the authors discussed this in connection with the low serum levels [1]. The frequently quoted ratio of 77 : 17 : 6 comes from general figures for the turmeric rhizome (curcumin about 77%, demethoxycurcumin about 17%, bisdemethoxycurcumin 3–6%) and is not a specification of C3 Complex [3]. For comparison: turmeric powder contains only about 2–6% curcuminoids [2], on average 3.14% curcumin in pure powder [4].

This extract was examined in a dose-escalation study with 24 healthy volunteers as single doses of 500 to 12,000 mg. Seven people had only minor complaints that did not appear dose-related. No curcumin was detected in serum up to 8,000 mg, and only low amounts in two people at 10,000 or 12,000 mg. The authors rated tolerance of high single doses as excellent [1]. So in this study hardly any curcumin was detectable in serum; it says nothing about daily intake or health effects.

What this means in practice

"C3 Complex" tells you about composition (high curcuminoid content), not about absorption or effect. In one study in healthy people, hardly any curcumin was detectable in serum after single doses of this powder. Whether a product really contains C3 Complex and how many curcuminoids it provides is stated by the manufacturer.

Limits of the statement

The information comes from a single small single-dose study and from one review. Manufacturer specifications are not independent evidence. Effects and safety with daily intake were not examined here.

Common follow-up questions

C3 Complex is a curcuminoid mixture with curcumin as its main component (Obregón-Mendoza et al., 2025) DOI. Turmeric powder contains on average about 3% curcumin and varies by product (Tayyem et al., 2006) DOI. These sources do not show that C3 Complex is absorbed better than powder; that was not compared here.

C3 Complex refers to a mixture of the three curcuminoids curcumin, demethoxycurcumin and bisdemethoxycurcumin (Obregón-Mendoza et al., 2025) DOI; piperine is not part of it. Some products add piperine separately; in a small study it raised the bioavailability of 2 g curcumin by 2000% (Shoba et al., 1998) DOI. Whether a product contains piperine is stated on its label.

C3 Complex is a standard curcuminoid mixture; micellar curcumin is a formulation in which curcumin is carried in micelles. In a crossover study of 23 healthy people, the AUC after 500 mg curcuminoids as liquid micelles was 185-fold higher overall than with native powder (Schiborr et al., 2014) DOI. A direct comparison with C3 Complex is missing.

This is plausible: in a crossover trial, absorption of curcuminoids was higher when given in food matrices, particularly those containing lipids in suspended form or polar lipids (Schönenberger et al., 2025) DOI. Whether this applies specifically to C3 Complex was not tested there.

Read more

Want to go deeper into the subject? Here is where to continue:

  • Intake guide: Useful information on bioavailability, modern formulations and the role of bioenhancers.
  • Safety check: A detailed look at safety, interactions and potential risks.
  • Effects overview: Answers to general questions about the effects and areas of use of the turmeric active ingredient.

References

  • [1] Lao, C. D. et al. (2006). Dose escalation of a curcuminoid formulation. BMC Complementary and Alternative Medicine. DOI: 10.1186/1472-6882-6-10
  • [2] Gupta, S. C., Patchva, S. & Aggarwal, B. B. (2013). Therapeutic roles of curcumin: lessons learned from clinical trials. The AAPS Journal. DOI: 10.1208/s12248-012-9432-8
  • [3] Kotha, R. R. & Luthria, D. L. (2019). Curcumin: biological, pharmaceutical, nutraceutical, and analytical aspects. Molecules. DOI: 10.3390/molecules24162930
  • [4] Tayyem, R. F. et al. (2006). Curcumin content of turmeric and curry powders. Nutrition and Cancer. DOI: 10.1207/s15327914nc5502_2